Current
$872M
5-Year Average
$282M
All-Time High
$955M
All-Time Low
$76.2M
Market cap daily chart for Climb Bio (CLYM)
Sep 9, 2024 – Jul 27, 2026 · 471 trading days
Market Cap growth chart for Climb Bio (CLYM) from 2024 to 2026
Latest: +221.6%
Market Cap history table for Climb Bio (CLYM) from 2024 to 2026
| 2026 | $872M | +221.6% | +$601M | ||
| 2025 | $271M | +212.9% | +$185M | ||
| 2024 | $86.7M | — | — |
- 2026$872M+221.6%
- 2025$271M+212.9%
- 2024$86.7M—
Market Cap values are taken from Climb Bio's reported income statements (share counts) and end-of-day prices (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Market Cap at Climb Bio (CLYM)
According to Climb Bio's latest reported financial statements, the company's latest reported market cap is $467M. Market capitalization is the total dollar value of all outstanding shares — shares outstanding × stock price — and the standard measure of a company's equity value. On this page, historical market cap snaps filing-period share counts to closing prices on or before each statement date (not intraday tick data).
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
Climb Bio (CLYM) most recent annual market cap stands at $872M (2026) – surged 221.6% year-over-year.
Climb Bio Market Cap by Year
Climb Bio Market Cap 2026: $872M
Climb Bio market cap in 2026 was $872M, surged 221.6% from 2025. This figure represents the highest annual value in the available history.
Climb Bio Market Cap 2025: $271M
2025's market cap for Climb Bio came in at $271M, surged 212.9% from 2024.
Climb Bio Market Cap 2024: $86.7M
Climb Bio market cap in 2024 was $86.7M.
See more financial history for Climb Bio (CLYM).
Sector peers by Market Cap
Healthcare peers of Climb Bio (CLYM), ranked by their latest market cap
| $1.13T | |
| $640B | |
| $454B | |
| $379B | |
| $323B | |
| $221B | |
| $208B | |
| $203B |
- $1.13T
- $454B
- $323B
- $221B
- $203B
Frequently asked questions
Test yourself on CLYM
Market Cap — 10 rounds, every one of them CLYM against another company. Leave whenever you like.
Practice run — it doesn’t move your skill rating and doesn’t touch the leaderboards. Misses do go into your review queue.
Climb Bio (CLYM) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
How this company returns cash to shareholders — buybacks, dividends, and stock splits.